Type:

Other

Description:

Access to the article is free, however registration and sign-in are required. As the anthrax bioterrorism attacks demonstrated last year, individuals infected with the causative organism, Bacillus anthracis, may still die even after successful antibiotic treatment because of the production of large amounts of the anthrax toxin. In their Perspective, Bull and Parrish discuss new work published elsewhere that identifies an antitoxin antibody that could be used to passively immunize infected individuals and neutralize the anthrax toxin.

Subjects:

    Education Levels:

      Keywords:

      vaccines,NSDL,antitoxin antibody,NSDL_SetSpec_BEN,bioterrorism,anthrax toxin,immunity to anthrax,protective antigen (PA),tripartite toxin,Bacillus anthracis,oai:nsdl.org:2200/20110722031005007T

      Language:

      English

      Access Privileges:

      Public - Available to anyone

      License Deed:

      Creative Commons Attribution Non-Commercial Share Alike

      Collections:

      None
      This resource has not yet been aligned.
      Curriki Rating
      'NR' - This resource has not been rated
      NR
      'NR' - This resource has not been rated

      This resource has not yet been reviewed.

      Not Rated Yet.

      Non-profit Tax ID # 203478467